Jochen Schuhmacher

Title: Jochen Schuhmacher: Innovator in Transdermal Therapeutic Systems

Introduction

Jochen Schuhmacher is a notable inventor based in Bucha, Germany. He has made significant contributions to the field of transdermal therapeutic systems, particularly with his innovative approach to UV stability in therapeutic plasters. His work has implications for the pharmaceutical industry, enhancing the effectiveness and safety of drug delivery systems.

Latest Patents

Schuhmacher holds a patent for a UV stable transdermal therapeutic plaster with a UV absorbing adhesive layer separated from the drug matrix. This invention relates to a transdermal therapeutic system (TTS) that includes a back layer, a matrix containing an active substance, and an optional withdrawal film along with a UV-radiation absorber. The adhesive layer, which contains the UV-radiation absorber, is strategically placed between the back layer and the active substance matrix. A separation layer is also included to ensure that the adhesive layer is as distant as possible from the surface, creating a barrier that is impermeable to both the active substance and the UV radiation absorber. This innovative system demonstrates high stability and addresses the challenges faced by existing TTS that contain light-sensitive substances. Schuhmacher's patent is a testament to his ingenuity, with 1 patent to his name.

Career Highlights

Throughout his career, Jochen Schuhmacher has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Bayer IP GmbH and Bayer Schering Pharma AG. His experience in these organizations has allowed him to refine his expertise in drug delivery systems and contribute to advancements in the field.

Collaborations

Schuhmacher has collaborated with esteemed colleagues such as Manfred Suesse and Michael Dittgen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the industry.

Conclusion

Jochen Schuhmacher's contributions to transdermal therapeutic systems highlight his role as an innovator in the pharmaceutical field. His patented technology offers significant advancements in drug delivery, ensuring both efficacy and safety. His work continues to influence the development of therapeutic systems that meet the needs of patients and healthcare providers alike.